INTRODUCTION {#sec1-1}
============

Cerebrospinal fluid (CSF) fistulas and postoperative hematomas constitute two of the major complications of spinal surgery.\[[@ref2][@ref13][@ref21]\] Fibrin sealants supplement dural closure and promote hemostasis.\[[@ref5][@ref16][@ref18]\] This study reports the preliminary results of utilizing a new fibrin sealant Vivostat^®^ (Vivostat A/S, Alleroed, Denmark) to achieve both hemostasis and facilitate dural repair in spinal surgery.

MATERIALS AND METHODS {#sec1-2}
=====================

From January 2013 to March 2015, 68 patients undergoing spinal surgery received autologous fibrin sealant prepared with the Vivostat^®^ system and applied epidurally, over the resection bed.

Patients population {#sec2-1}
-------------------

Upon approval of the local Institutional Review Board, between January 2013 and March 2015 we performed 68 neurosurgical spinal procedures utilizing autologous fibrin sealant/Vivostat^®^ to achieve hemostasis and/or to seal the dura.

In 47% of cases (32 cases), the autologous fibrin glue was used only as an hemostatic agent; in 34% of cases it was used both as an hemostatic and dural sealant agent for strengthening atretic dura (without frank CSF fistula); in 19% of cases the autologous fibrin glue was used to achieve both hemostasis and CSF fistula repair; \[[Table 1](#T1){ref-type="table"}\]. In the majority of cases, autologous fibrin glue addressed degenerative disease (43%) or tumor (oncological cases: 32%) \[[Table 1](#T1){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}\]. For Vivostat preparation and administration see Graziano *et al*. and Giugno *et al*.\[[@ref6][@ref7][@ref8]\] All patients were monitored postoperatively for an average of 18 months.

###### 

Patient data including the vertebro-spinal procedures performed
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![Graph showing the percentage of the pathologies included in the study](SNI-7-77-g002){#F1}

RESULTS {#sec1-3}
=======

Technical and economic considerations {#sec2-2}
-------------------------------------

This system was effective in all three circumstances; as a hemostatic alone, as a hemostatic and to strengthen atretic dura, and for hemostasis and dural repair. The Notably, Vivostat^®^ formed an extremely thin white coat and did not compress the neural structures; additionally, it was physiologically eliminated within 24--36 h \[[Figure 2](#F2){ref-type="fig"}\]. Only in 2 cases postoperative CSF fistulas were encountered; 1 was successfully treated conservatively while the other required additional dural repair \[[Table 1](#T1){ref-type="table"}\]. Notably, no local medullar toxicity, allergic reactions, infection, or systemic complications occurred. The cost per kit needed (e.g., automated preparation of 6.5 ml of fibrin glue) is around 700 USD. Each procedure typically requires only kit; only 5--10% of cases may require two kits.

![Cauda equina neurinoma. (a) Preoperative Magnetic resonance (MR), T1-weighted sagittal view: An iperintense homogeneous enhancing circular lesion is visible posterior to the disc space L1--L2. (b) Intraoperative picture of the intradural lesion. (c) After the lesion removal, the dura mater is closed in watertight fashion with single stitches. (d) The autologous fibrin glue is applied on the reconstructed dural layer in order to achieve a satisfactory dural sealing](SNI-7-77-g003){#F2}

DISCUSSION {#sec1-4}
==========

Application for durotomies and hemostasis {#sec2-3}
-----------------------------------------

In spinal surgery, the major intraoperative complications are typically due to accidental durotomies or postoperative hematomas. Cammisa *et al*. found 66 (3.1%) durotomies occurring during 2144 spinal operations; they were immediately treated with dural suturing and fibrin glue.\[[@ref4]\] During minimally invasive spine surgery, the durotomy incidence has been estimated to be 9%, 4% among 563 patients in the case series of Ruban and O'Toole.\[[@ref17]\]

Do dural sealants inhibit fusion {#sec2-4}
--------------------------------

Some are concerned whether these sealants on the vertebral fusion rate.\[[@ref5]\] Turgut *et al*. assessed the impact of Tisseel on anterior cervical interbody allograft fusion at the C5--C6 level in cats (12 received Tisseel, 12 did not); it was not suitable for "fixation of bone fragments" for anterior cervical discectomy and fusion in this cat model.\[[@ref22]\] Landi *et al*. determined the efficacy of utilizing a topical platelet gel to supplement posterolateral fusions rates in 14 instrumented fusions; fusion rates were comparable for both groups at 6 postoperative months.\[[@ref12]\]

Arguments favoring utilization of Vivostat system {#sec2-5}
-------------------------------------------------

The Vivostat^®^ system is successfully used in several specialties.\[[@ref1][@ref3][@ref10][@ref11][@ref14][@ref15][@ref19][@ref20]\] The autologous nature of Vivostat^®^ eliminates the risks of bovine or human-borne contaminants, protecting the patient against viral diseases. It provides rapid polymerization, set rapidly, and provides instant tissue-fibrin adhesion, enabling the surgeon to manipulate the treated area early.\[[@ref9][@ref23]\] In our clinical series, the Vivostat^®^ provided immediate hemostasis without compression of neural tissues. Furthermore, there were 2 cases complicated by postoperative CSF fistula out of 68 patients treated, but only one required repeated surgical intervention.

CONCLUSION {#sec1-5}
==========

Vivostat^®^ system appears to be a safe/effective fully autologous hemostatic and dural sealant agent. Its composition and mechanism of action makes it able to adhere immediately to tissues and its rapid degradation time avoids any potential long-term mass effect.
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